A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice.
Ontology highlight
ABSTRACT: Sterile stimuli can trigger inflammatory responses, and in some cases can lead to a variety of acute or chronic diseases. In this study, we hypothesize that a benzimidazole inhibitor may be used as a therapeutic in the treatment of sterile inflammation. In vitro, this inhibitor blocks TLR signalling and inflammatory responses. The benzimidazole inhibitor does not prevent mouse macrophage activation after stimulation with 2,6,10,14-tetramethylpentadecane (TMPD, also known as pristane), a hydrocarbon oil that mimics features of sterile inflammation when injected in vivo. However, C57BL/6J female mice treated with the benzimidazole inhibitor exhibited a significant reduction of pristane-dependent induction of splenocyte number and weight. Conversely, no significant difference was observed in
SUBMITTER: Agliano F
PROVIDER: S-EPMC7374700 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA